📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Pediatric tuberculous meningitis: Model-based approach to determining optimal doses of the anti-tuberculosis drugs rifampin and levofloxacin for children. (2015)

First Author: Savic RM

Attributed to: A phase III cluster randomised placebo-controlled trial to assess the efficacy of preventive therapy in child and adolescent contacts of MDR-TB funded by GCRF

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/cpt.202

PubMed Identifier: 26260983

Publication URI: http://europepmc.org/abstract/MED/26260983

Type: Journal Article/Review

Volume: 98

Parent Publication: Clinical pharmacology and therapeutics

Issue: 6

ISSN: 0009-9236